No products in your basket.
Purchase your test with
Price range: £299.00 through £459.00
Veracity NIPT is a prenatal screening test available from 10 weeks of pregnancy. By analysing small pieces of placental DNA in a maternal blood sample, it estimates whether selected chromosome conditions are more or less likely.
Four options let you choose how much information you want, beginning with focused screening for the three most common trisomies and extending to selected sex chromosome conditions and microdeletions. Through My DNA Lab, you can access Veracity privately and use the report to support an informed conversation with your midwife, GP or obstetric team.
A qualified healthcare professional must collect the blood sample. You can arrange this locally or use My DNA Lab’s mobile phlebotomy service within mainland UK. Once your sample is ready, contact us and we will arrange its return to the laboratory.
During pregnancy, small pieces of DNA from the placenta circulate in the pregnant woman’s blood. This is called cell-free DNA. Veracity analyses this DNA to estimate whether there is a lower or higher chance of the conditions included in your chosen option.
All four options screen for trisomy 21 (Down’s syndrome), trisomy 18 (Edwards’ syndrome) and trisomy 13 (Patau’s syndrome). The clearest difference begins with fetal-sex information: Core without Gender is the only option that does not include it, while Core with Gender, Plus and Advanced all include it where technically available. Plus and Advanced also screen for selected sex chromosome conditions, and Advanced adds DiGeorge syndrome (22q11.2), 1p36 deletion syndrome, Smith-Magenis syndrome (17p11.2), Wolf-Hirschhorn syndrome (4p16.3), Prader-Willi and Angelman syndromes (15q11.2-q13), and Cri-du-chat syndrome (5p). You can review the full scope in the Veracity brochure under ‘Test provider and further information’ further down this page.
However, Veracity remains a screening test rather than a diagnosis. It does not assess every chromosome or genetic condition, and a lower-chance result cannot guarantee that a baby is unaffected. For Prader-Willi and Angelman syndromes, screening is limited to full-region deletions at 15q11.2-q13, while Cri-du-chat screening is limited to qualifying terminal deletions within 5p.
Veracity may suit you from 10 weeks of pregnancy if you want a choice between focused and wider chromosome screening. Some options can be used for singleton, twin and IVF pregnancies, although eligibility and the information that can be reported depend on the option and pregnancy type.
If you know that you are expecting twins or triplets, the pregnancy has involved a vanishing twin, or donor eggs or sperm, IVF or a surrogate are involved, contact My DNA Lab before purchasing. We can confirm the current eligibility and sample requirements before you choose an option.
If an ultrasound scan or family history has already raised a concern about a particular condition, Veracity may not answer that specific question. In that situation, a different or more focused clinical test may provide a clearer answer.
The prices above apply when blood collection is arranged with your own qualified healthcare professional. Alternatively, My DNA Lab’s mobile phlebotomy service is available within mainland UK for an additional £60.
Your report gives a lower-chance or higher-chance result for every condition included in your option. Every option except Core without Gender may also report fetal sex where this is technically available.
A lower-chance result makes the screened conditions less likely, but it cannot rule them out. Equally, a higher-chance result does not confirm that the baby has a condition. We always recommend that you discuss your results with your healthcare professional; a higher-chance result should be shared promptly with your midwife or obstetric team, who may discuss diagnostic testing such as CVS or amniocentesis.
If you receive a higher-chance result, you can request an additional written report from the provider free of charge, although it is not issued automatically. A telephone consultation with the provider is also available for €150, subject to change. Contact My DNA Lab and we will explain how to request either form of support. Your maternity team remains responsible for pregnancy care and any further diagnostic testing.
Core without Gender provides focused screening for trisomy 21, 18 and 13 without fetal-sex information. Core with Gender adds fetal sex where technically available. Plus then adds selected sex chromosome conditions, while Advanced adds the selected microdeletions listed above. This step-by-step structure makes it easier to choose the level of information that is relevant to you.
Although wider screening provides more information, it can also produce findings that are harder to interpret. When comparing the options, consider the scope, pregnancy eligibility and reporting limits as well as the price, and think about what you would want to do if the report showed a higher-chance result.
Whatever option you choose, continue every routine antenatal appointment, ultrasound scan and screening test offered by your maternity team. Seek prompt advice about pain, bleeding, reduced movements or another pregnancy concern rather than waiting for a private test or result.
